Drugs / 5-flurouracil
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01212718 | Jul 2001 → Jun 2010 | metastasis from malignant tumor of colon | University of Ulm | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00705874 Background | May 2006 → Aug 2011 | cancer | Progen Pharmaceuticals | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03699319 Background | Dec 2018 → Sep 2024 | pancreatic ductal adenocarcinoma | David Bajor, MD | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03290820 Background | Jan 2018 → Sep 2024 | nasopharyngeal carcinoma | Sun Yat-sen University | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT07276399 Comparator | Dec 2025 → Jun 2029 expected | head and neck squamous cell carcinoma | Janssen Research & Development, LLC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5-flurouracil | “Nedaplatin 80mg/m2 d1+5-flurouracil 500mg/m2 d2-5, every 3 weeks; a total of 2-3 cycles.” NCT03290820 ↗ |
| Route | Intravenous | “5 - FU 500 mg/m2 IV bolus” NCT00705874 ↗ |